These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8732555)

  • 1. Tolerance of initial diphtheria-tetanus-pertussis immunization in preterm infants.
    Topsis J; Kandall S; Weinstein J; Wilets I
    J Perinatol; 1996; 16(2 Pt 1):98-102. PubMed ID: 8732555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.
    Batra JS; Eriksen EM; Zangwill KM; Lee M; Marcy SM; Ward JI;
    Pediatrics; 2009 Mar; 123(3):951-8. PubMed ID: 19255025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events.
    Pfister RE; Aeschbach V; Niksic-Stuber V; Martin BC; Siegrist CA
    J Pediatr; 2004 Jul; 145(1):58-66. PubMed ID: 15238908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Romero A; Lopez G; Dal-Ré R
    Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to immunization with newer vaccines in the very preterm infant.
    Ellison VJ; Davis PG; Doyle LW
    J Paediatr Child Health; 2005 Aug; 41(8):441-3. PubMed ID: 16101980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of DTaP-IPV-HIb-HBV hexavalent vaccine in very premature infants.
    Faldella G; Galletti S; Corvaglia L; Ancora G; Alessandroni R
    Vaccine; 2007 Jan; 25(6):1036-42. PubMed ID: 17088013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants.
    Vázquez L; Garcia F; Rüttimann R; Coconier G; Jacquet JM; Schuerman L
    Acta Paediatr; 2008 Sep; 97(9):1243-9. PubMed ID: 18489623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis immunization patterns in special care nursery graduates.
    Ruiz P; Nathanson R; Kastner T
    J Dev Behav Pediatr; 1991 Feb; 12(1):38-41. PubMed ID: 2016401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of preterm infants.
    Peter G
    Pediatrics; 1993 Jan; 91(1):168-9. PubMed ID: 8457271
    [No Abstract]   [Full Text] [Related]  

  • 12. [Seroconversion after vaccination against pertussis, Haemophilus influenzae type b and poliomyelitis in preterm infants].
    Sikora JP; Chlebna-Sokół D
    Przegl Lek; 2003; 60(11):699-703. PubMed ID: 15058036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunization of premature infants with gestational age <35 weeks: cardiorespiratory complications and C-reactive protein responses associated with administration of single and multiple separate vaccines simultaneously.
    Pourcyrous M; Korones SB; Arheart KL; Bada HS
    J Pediatr; 2007 Aug; 151(2):167-72. PubMed ID: 17643770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for developing apnea after immunization in the neonatal intensive care unit.
    Klein NP; Massolo ML; Greene J; Dekker CL; Black S; Escobar GJ;
    Pediatrics; 2008 Mar; 121(3):463-9. PubMed ID: 18310193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.